文献速递类风湿关节炎

类风湿关节炎腱鞘组织的微创获取与表征:研究高危、活动和缓解阶段的新方法

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages.
PubMed 文献 · Ann Rheum Dis · 2025-03-27

该研究分析了834例腕部MRI扫描,评估临床疑似关节痛(CSA)、未治疗类风湿关节炎(RA)和健康对照的腱鞘炎发生率,并开发超声引导微创技术获取腕伸肌腱腱鞘组织,在独立队列中比较CSA、RA和骨关节炎患者的组织学特征。结果显示腱鞘炎在CSA和RA中常见,腱鞘组织可安全获取,活动性RA的滑膜增生和炎症浸润显著高于无亚临床炎症的CSA和RA缓解期,与相邻炎症滑膜相当。

要点

  • 腕伸/屈肌腱腱鞘炎在CSA中占34%、RA中占68%,健康对照占8%。
  • 超声引导微创获取腱鞘组织的成功率为89.7%,未发生严重不良事件。
  • 活动性RA的腱鞘滑膜增生和炎症浸润显著高于无超声亚临床炎症的CSA和RA缓解期。

核心结论

  • 腱鞘在CSA和RA中频繁发生炎症且易于获取,未来对腱鞘活检的分子研究将增进对从临床前期RA向RA转变的理解。

研究设计与样本

  • 分析834例腕部MRI扫描(168例自身抗体阳性CSA、473例未治疗RA、193例健康对照)评估腱鞘炎发生率。
  • 开发超声引导微创技术,在独立队列中获取腕伸肌腱腱鞘组织:16例自身抗体阳性CSA、41例RA(其中14例获取相邻滑膜且超声检测炎症程度可比)、8例骨关节炎患者。
  • 采用苏木精-伊红染色和免疫组化(CD55、CD68、CD3、CD20、CD138、CD21)评估组织代表性、滑膜衬里增生和炎症浸润程度,并评估安全性和耐受性。

主要发现

  • 腕伸/屈肌腱腱鞘炎在CSA中占34%、RA中占68%,健康对照中占8%。
  • 腱鞘组织获取成功率为89.7%,未发生严重不良事件。
  • 活动性RA的腱鞘滑膜衬里增生和炎症浸润显著高于无超声检测亚临床炎症的CSA患者和RA缓解期患者,与相邻炎症滑膜相当。
  • 伴有亚临床炎症的CSA患者与骨关节炎对照相比,显示早期CD3阳性细胞和CD55阳性细胞富集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tenosynovial inflammation is a hallmark of rheumatoid arthritis (RA), even in the preclinical phase. However, tenosynovium retrieval and characterisation is beyond the current state-of-the-art. We aimed to (1) assess the rate of magnetic resonance imaging (MRI)-detected tenosynovitis in the wrists of patients with preclinical and clinical RA; (2) develop a technique for tenosynovium retrieval; and (3) characterise its cellular composition across disease phases, including the comparison to adjacent synovium. METHODS: In total, 834 MRI wrist scans were analysed to assess extensor/flexor tendon tenosynovitis rate (168 autoantibody-positive clinical suspect arthralgia (CSA), 473 naïve to treatment RA, and 193 healthy controls). An ultrasound-guided minimally invasive technique was developed to collect tenosynovium from the wrist extensor tendons in an independent cohort: 16 autoantibody-positive CSA patients, 41 RA patients (14 of whom with adjacent synovium with comparable ultrasound-detected inflammation), and 8 osteoarthritis (OA) patients. Tissue representativity, lining hyperplasia, and inflammatory infiltrate degree were assessed by haematoxylin and eosin staining and immunohistochemistry (CD55, CD68, CD3, CD20, CD138, and CD21). Safety and tolerability were assessed. RESULTS: Tenosynovitis of the wrist extensors/flexor tendons was observed in 34% of CSA and 68% of RA patient compared to 8% in healthy. Tenosynovium was successfully retrieved in 89.7% of cases without severe adverse events. Tenosynovial lining hyperplasia and inflammatory infiltrate were significantly higher in active RA than CSA patients without ultrasound-detected subclinical inflammation and RA remission, and comparable to inflamed adjacent synovium. CSA patients with subclinical inflammation showed early CD3pos and CD55pos cells enrichment compared to OA controls. CONCLUSIONS: Tenosynovium is frequently inflamed and readily accessible in CSA and RA. Future molecular studies of tenosynovial biopsies will advance understanding of the transition from pre-RA to RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Coletto LA, van Steenbergen HW, Di Mario C, et al. Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages. Ann Rheum Dis. 2025. PMID: 40148202. doi:10.1016/j.ard.2025.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。